5Reith JD, Goldblum JR, Lyles RH, et al. Extragastrointestinal (soft tissue) stromal tumors: an analysis of 48 cases with emphasis on histologic predictors of outcome.Mod Pathol,2000,13:577-585.
6Zighelboim I, Henao G, Kunda A, et al. Gastrointestinal stromal tumor presenting as a pelvic mass.Gynecol Oncol,2003,91:630-635.
7Krokowski M, Jocham D, Choi H, et al. Malignant extragastrointestinal stromal tumor of bladder.J Urol,2003,169:1790-1791.
8Emory TS, Sobin LH, Lukes L, et al. Prognosis of gastrointestinal smooth-muscle (stromal) tumors: dependence on anatomic site.Am J Surg Pathol,1999,23:82-87.
9Dematteo RP, Heinrich MC, El-Rifai WM, et al. Clinical management of gastrointestinal stromal tumors: before and after STI-571.Hum Pathol,2002,33:466-477.
10Verweij J, van Oosterom A, Blay JY, et al. Imatinib mesylate (STI-571 Glivec, Gleevec) is an active agent for gastrointestinal stromal tumours, but does not yield responses in other soft-tissue sarcomas that are unselected for a molecular target. Results from an EORTC Soft Tissue and Bone Sarcoma Group phase II study.Eur J Cancer,2003,39:2006-2011.
5Bost REJ, Xu FJ, YU YH et al. CA125, the past and the future [J] . lnt J Biol Markers, 1998, 13 (4) : 179.
6Takekawa Y, Kinura M, Sakaibara M et al. Pathological cytological and immunoh istochemical study of nomal sized ovary carcinoma syndrome [J] .RinshoByori, 2001, 49 (1): 66.
8Wenandy L, Sφrensen RB, Svane IM, et al. RhoC a new target for therapeutic vaccination against metastatic cancer [ J ]. Cancer Immunol Immunother, 2008, 27 (8): 1135-1139.
9Liu N, Zhang G, Bi F, et al. RhoC is essential for the metastasis of gastric cancer [J]. J Mol Med, 2007, 85 (10) : 1149 -1156.
10Wheeler AP, Ridley AJ. Why three Rho proteins? RhoA, RhoB, RhoC, and cell motility [J].Exp Cell Res, 2004, 301 (1) : 43 - 49.
